Company / Inventory per Share
Sarepta Therapeutics Inventory per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$9.44
FY2025
5-year range
$2.34 / $9.44
FY2021-FY2025
Trend
+18.0%
vs FY2024
Sector context
#7 of 105
Health Care
What the data says
Among 105 Health Care companies, Sarepta Therapeutics is in the top 7% for inventory per share. Inventory per Share has increased for 3 consecutive years, from $2.34 in FY2022 to $9.44 in FY2025.
Based on SEC 10-K filings.
9.44 in FY2025 with a 5-year CAGR of +25.1%. Top quartile in the Health Care sector.
Improved from $3.67 to $9.44 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +59.2%
- 5-Year CAGR
- +25.1%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 105This company $9.44 Sector average $30.82
▼
-69.4% below sector average
Key checks
Key Insights
- Sarepta Therapeutics's inventory per share has grown for 3 consecutive years.
- In FY2025, inventory per share increased 18.0% year-over-year.
- Ranks #7 out of 105 companies in the Health Care sector.
- Lowest inventory per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.44 | +18.0% |
| FY2024 | $8.00 | +118.0% |
| FY2023 | $3.67 | +56.8% |
| FY2022 | $2.34 | -0.2% |
| FY2021 | $2.35 | -24.0% |
| FY2020 | $3.09 | +27.9% |
| FY2019 | $2.41 | +24.5% |
| FY2018 | $1.94 | +26.8% |
| FY2017 | $1.53 | +443.7% |
| FY2016 | $0.28 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026